M. Begoña López Salazar-rekin lankidetzan egindako argitalpenak (42)

2020

  1. Cardiorenal interaction and heart failure outcomes. A role for insulin-like growth factor binding protein 2?

    Revista Espanola de Cardiologia, Vol. 73, Núm. 10, pp. 835-843

2019

  1. CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) axis in cardiac fibrosis and inflammation: Mechanistic insights and clinical implications

    Hypertension, Vol. 73, Núm. 3, pp. 602-611

  2. Circulating long noncoding RNA LIPCAR Predicts heart failure outcomes in patients without chronic kidney disease

    Hypertension, Vol. 73, Núm. 4, pp. 820-828

  3. Combination of Circulating Type I Collagen-Related Biomarkers Is Associated With Atrial Fibrillation

    Journal of the American College of Cardiology, Vol. 73, Núm. 12, pp. 1398-1410

2018

  1. Myocardial remodeling in hypertension toward a new view of hypertensive heart disease

    Hypertension, Vol. 72, Núm. 3, pp. 549-558

2017

  1. Hypertensive Heart Disease

    Encyclopedia of Cardiovascular Research and Medicine (Elsevier), pp. 517-526

  2. Papel del colágeno miocárdico en la estenosis aórtica grave con fracción de eyección conservada y síntomas de insuficiencia cardiaca

    Revista Espanola de Cardiologia, Vol. 70, Núm. 10, pp. 832-840

  3. Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome

    Journal of Hypertension, Vol. 35, Núm. 4, pp. 853-861

2016

  1. Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: Potential role of altered collagen metabolism

    Journal of Hypertension, Vol. 34, Núm. 1, pp. 130-138

  2. Myocardial collagen cross-linking is associated with heart failure hospitalization in patients with hypertensive heart failure

    Journal of the American College of Cardiology, Vol. 67, Núm. 3, pp. 251-260

2015

  1. Circulating biomarkers of myocardial fibrosis: The need for a reappraisal

    Journal of the American College of Cardiology, Vol. 65, Núm. 22, pp. 2449-2456

  2. Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin

    European Journal of Heart Failure, Vol. 17, Núm. 4, pp. 385-392

2014

  1. Association of cardiotrophin-1 with myocardial fibrosis in hypertensive patients with heart failure

    Hypertension, Vol. 63, Núm. 3, pp. 483-489

2013

  1. Osteopontin-mediated myocardial fibrosis in heart failure: A role for lysyl oxidase?

    Cardiovascular Research, Vol. 99, Núm. 1, pp. 111-120

2012

  1. Collagen cross-linking but not collagen amount associates with elevated filling pressures in hypertensive patients with stage C heart failure: Potential role of lysyl oxidase

    Hypertension, Vol. 60, Núm. 3, pp. 677-683

2010

  1. Filling pressures and collagen metabolism in hypertensive patients with heart failure and normal ejection fraction

    Hypertension, Vol. 55, Núm. 6, pp. 1418-1424

2009

  1. Association of plasma cardiotrophin-1 with stage C heart failure in hypertensive patients: Potential diagnostic implications

    Journal of Hypertension, Vol. 27, Núm. 2, pp. 418-424

  2. Impact of treatment on myocardial lysyl oxidase expression and collagen Cross-linking in patients with heart failure

    Hypertension, Vol. 53, Núm. 2, pp. 236-242

2007

  1. Association of depressed cardiac gp130-mediated antiapoptotic pathways with stimulated cardiomyocyte apoptosis in hypertensive patients with heart failure

    Journal of Hypertension, Vol. 25, Núm. 10, pp. 2148-2157

  2. Identification of a Potential Cardiac Antifibrotic Mechanism of Torasemide in Patients With Chronic Heart Failure

    Journal of the American College of Cardiology, Vol. 50, Núm. 9, pp. 859-867